E9-20895. Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Guidance for Industry on Formal Dispute Resolution; Appeals Above the Division Level  

  • Start Preamble

    AGENCY:

    Food and Drug Administration, HHS.

    ACTION:

    Notice.

    SUMMARY:

    The Food and Drug Administration (FDA) is announcing that a collection of information entitled “Guidance for Industry on Formal Dispute Resolution; Appeals Above the Division Level” has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    Elizabeth Berbakos, Office of Information Management (HFA-710), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, Elizabeth.Berbakos@fda.hhs.gov, 301-796-3792.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    In the Federal Register of April 28, 2009 (74 FR 19225), the agency announced that the proposed information collection had been submitted to OMB for review and clearance under 44 U.S.C. 3507. An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. OMB has now approved the information collection and has assigned OMB control number 0910-0396. The approval expires on August 31, 2012. A copy of the supporting statement for this information collection is available on the Internet at http://www.reginfo.gov/​public/​do/​PRAMain.

    Start Signature

    Dated: August 21, 2009.

    David Horowitz,

    Assistant Commissioner for Policy.

    End Signature End Supplemental Information

    [FR Doc. E9-20895 Filed 8-28-09; 8:45 am]

    BILLING CODE 4160-01-S

Document Information

Comments Received:
0 Comments
Published:
08/31/2009
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
E9-20895
Pages:
44855-44855 (1 pages)
Docket Numbers:
Docket No. FDA-2008-N-0565
PDF File:
e9-20895.pdf